📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 16:32
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Citurgia Biochemicals Reports Zero Revenue and Rs 8.20 Lakh Net Loss for Q1 FY27
Citurgia Biochemicals continues to report zero operational revenue for the quarter ended June 30, 2026, maintaining a trend of operational dormancy. The company recorded a net loss of Rs 8.20 lakhs, which is a marginal improvement from the Rs 8.39 lakh loss in the same quarter last year and a significant reduction from the Rs 25.82 lakh loss in the preceding quarter. Expenses were primarily driven by depreciation (Rs 5.15 lakhs) and employee benefits (Rs 3.00 lakhs). With a negative net worth of Rs 8 crore and zero TTM revenue, the company's financial position remains extremely weak.
Confidence: HIGH
What changedThe company released its unaudited financial results for Q1 FY27, confirming a continued lack of business activity and ongoing net losses.
Why it mattersThe company is effectively dormant with no revenue and eroding capital; the negative net worth of Rs 8 crore indicates significant insolvency risk.
Total Revenue: Rs 0.00Net Loss: Rs 8.20 LakhsEmployee Benefit Expenses: Rs 3.00 LakhsNet Worth: Rs -8 CrPromoter Holding: 99.36%
📅 Short termThe stock is likely to remain stagnant or under pressure given the lack of operational progress and continued losses.
📈 Long termThe long-term outlook is highly uncertain and limited unless there is a major restructuring or new business injection, given the negative net worth and zero revenue.
⚠ Risk flags
- Zero operational revenue
- Negative net worth of Rs 8 crore
- High promoter concentration (99.36%) limiting public float
- Persistent quarterly losses
Key Highlights
Total Income from operations remained at Rs 0.00 for the quarter ended June 30, 2026.
Net loss for the quarter stood at Rs 8.20 lakhs, compared to a loss of Rs 25.82 lakhs in the preceding quarter (March 2026).
Total expenses decreased to Rs 8.20 lakhs from Rs 25.82 lakhs in the previous quarter, largely due to lower 'Other Expenses'.
Employee benefit expenses remained constant at Rs 3.00 lakhs compared to the corresponding quarter of the previous year.
Depreciation and amortization expenses accounted for the largest portion of the loss at Rs 5.15 lakhs.
👀 What to Watch
Investors should monitor for any regulatory updates or management announcements regarding the revival of business operations, as the company currently generates no revenue and has a negative net worth.
